Challenges around accessible and affordable medicines have become even more pressing in light of the current COVID-19 pandemic. How can we ensure that publicly funded pharmaceuticals are accessible to patients in Europe and the rest of the world? And what changes do we need to see in EU policy? On Friday June 19th, Members of European Parliament Kim van Sparrentak, Sophie in ‘T Veld, Marc Botenga, together with Commons Network, Fair Medicine, Health Action International, License to Heal, Médecins Sans Frontières, Universities Allied for Essential Medicines NL, and Wemos will discuss these questions (and more) during the online roundtable webinar on ‘Covid-19 and beyond: the future of publicly funded pharmaceuticals to ensure affordable health for all’. Make sure to register!
Experts include Dr Ellen ’t Hoen (lawyer, director Medicines Law & Policy and former director of the Medicines Patent Pool) and Viviana Galli (coordinator European Alliance for Responsible R&D and Affordable medicines), and co-hosting NGOs and MEPs will join the discussion as well. The webinar will take place on Friday June 19th 2020, from 11:00-12:30. For more information and registration, please visit this link.
Update June 19 2020: Missed the live webinar or want to watch it again? Here is the YouTube link to the recording.